Myelosuppression
Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of June 5, 2023
In this edition, surgery confers higher 5-year survival rates than radiotherapy; first-line combination extends PFS in lung cancer subgroup; pembrolizumab improves outcomes in early-stage resectable lung cancer, and more.
Severe myelosuppression common after chemotherapy for small cell lung cancer
Nearly all individuals who received chemotherapy for extensive-stage small cell lung cancer experienced a treatment-related myelosuppressive episode, results of a retrospective study published in Cancer Medicine showed.
FDA approves Rolvedon to reduce infection incidence when taking certain anticancer drugs
The FDA approved eflapegrastim-xnst injection to reduce incidence of infection, as manifested by febrile neutropenia, in adults with nonmyeloid malignancies taking certain anticancer drugs, according to a company-issued press release.
FDA grants priority review to trilaciclib for small cell lung cancer
The FDA granted priority review to trilaciclib for treatment of patients with small cell lung cancer who are receiving chemotherapy, according to the agent’s manufacturer.